PEAK6 Investments’s ResMed RMD Stock Holding History

PEAK6 Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$4.38M	Buy	17,958 +15,657	+680%	+$3.5M	0.01%	1010
2024 Q2	$440K	Sell	2,301 -45,807	-95%	-$9.29M	﹤0.01%	2322
2024 Q1	$9.53M	Buy	48,108 +8,981	+23%	+$1.65M	0.02%	542
2023 Q4	$6.73M	Buy	39,127 +10,043	+35%	+$1.54M	0.02%	655
2023 Q3	$4.3M	Buy	29,084 +23,465	+418%	+$4.24M	0.02%	805
2023 Q2	$1.23M	Buy	+5,619	New	+$1.25M	0.01%	1568
2023 Q1	–	Sell	-6,697	Closed	-$1.39M	–	4859
2022 Q4	$1.39M	Buy	+6,697	New	+$1.47M	0.01%	1647
2022 Q3	–	Sell	-5,619	Closed	-$1.28M	–	5934
2022 Q2	$1.23M	Buy	5,619 +5,617	+280,850%	+$1.2M	﹤0.01%	2872
2022 Q1	$1K	Buy	+2	New	+$484	﹤0.01%	5063
2021 Q4	–	Sell	-2	Closed	-$519	–	5693
2021 Q3	$1K	Buy	+2	New	+$547	﹤0.01%	5020
2020 Q4	–	Sell	-6,623	Closed	-$1.32M	–	5059
2020 Q3	$1.14M	Buy	+6,623	New	+$1.22M	﹤0.01%	2154
2020 Q2	–	Sell	-516	Closed	-$84.4K	–	4757
2020 Q1	$76K	Buy	+516	New	+$82.2K	﹤0.01%	3435
2019 Q2	–	Sell	-23,850	Closed	-$2.48M	–	4201
2019 Q1	$2.48M	Buy	+23,850	New	+$2.46M	0.01%	1152

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

PEAK6 Investments's RMD Position: Q3 2024 in Review

PEAK6 Investments increased its ResMed (RMD) stake by 680% in Q3 2024, buying an estimated $3.5M and bringing the position to 17,958 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #1010.

PEAK6 Investments first reported a position in RMD in Q1 2019 and has held it in 13 quarters since. The position peaked at $9.53M in Q1 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

PEAK6 Investments held 17,958 shares of ResMed worth $4.38M as of Q3 2024.
PEAK6 Investments bought 15,657 ResMed shares in Q3 2024, an estimated $3.5M.
ResMed made up 0.01% of PEAK6 Investments's portfolio in Q3 2024, its #1010 holding.
PEAK6 Investments first reported a position in ResMed in Q1 2019 and has held it in 13 quarters since.
PEAK6 Investments's ResMed position peaked at $9.53M in Q1 2024.
801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.